267 related articles for article (PubMed ID: 16431839)
1. Analysis and recommendations for agency action regarding nonsteroidal antiinflammatory drugs and cardiovascular risk.
U.S. Food and Drug Administration
J Pain Palliat Care Pharmacother; 2005; 19(4):83-97. PubMed ID: 16431839
[TBL] [Abstract][Full Text] [Related]
2. COX-2 inhibitors and the heart: putting risk in perspective.
Bobadilla RV; Barnett EM; Randels CL
Adv Nurse Pract; 2005 Nov; 13(11):48-50. PubMed ID: 16295003
[No Abstract] [Full Text] [Related]
3. Evaluating drug effects in the post-Vioxx world: there must be a better way.
Avorn J
Circulation; 2006 May; 113(18):2173-6. PubMed ID: 16684873
[No Abstract] [Full Text] [Related]
4. Effect of dosage on coxib- or nonsteroidal antiinflammatory drug-associated cardiovascular risk? Comment on the article by Solomon et al.
Boers M
Arthritis Rheum; 2007 Jan; 56(1):384; author reply 384. PubMed ID: 17195242
[No Abstract] [Full Text] [Related]
5. The withdrawal of rofecoxib.
Arellano FM
Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):213-7. PubMed ID: 15724267
[No Abstract] [Full Text] [Related]
6. Cyclooxygenase-2 inhibitors and cardiovascular risk.
Solomon SD
Curr Opin Cardiol; 2006 Nov; 21(6):613-7. PubMed ID: 17053413
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
Vardeny O; Solomon SD
Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risks of cyclooxygenase inhibition.
Stacy ZA; Dobesh PP; Trujillo TC
Pharmacotherapy; 2006 Jul; 26(7):919-38. PubMed ID: 16803424
[TBL] [Abstract][Full Text] [Related]
9. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
Scheiman JM
Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
[TBL] [Abstract][Full Text] [Related]
10. Use of nonsteroidal antiinflammatory drugs: is there a change in patient risk profile after withdrawal of rofecoxib?
Rahme E; Roussy JP; Lafrance JP; Nedjar H; Morin S
J Rheumatol; 2011 Feb; 38(2):195-202. PubMed ID: 21078717
[TBL] [Abstract][Full Text] [Related]
11. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
Woodruff T
Intern Med J; 2006 Dec; 36(12):797-8; author reply 798-9. PubMed ID: 17096747
[No Abstract] [Full Text] [Related]
12. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.
Hennekens CH; Borzak S
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):41-50. PubMed ID: 18287589
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.
Joshi GP; Gertler R; Fricker R
Anesth Analg; 2007 Dec; 105(6):1793-804, table of contents. PubMed ID: 18042885
[TBL] [Abstract][Full Text] [Related]
15. Update on nonsteriodal anti-inflammatory drugs.
Ardoin SP; Sundy JS
Curr Opin Rheumatol; 2006 May; 18(3):221-6. PubMed ID: 16582683
[TBL] [Abstract][Full Text] [Related]
16. The Vioxx debacle revisited.
Mohapatra PR; Janmeja AK
Am J Med; 2005 Sep; 118(9):1058. PubMed ID: 16164909
[No Abstract] [Full Text] [Related]
17. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
Hermann M; Ruschitzka F
Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
[TBL] [Abstract][Full Text] [Related]
18. Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular events.
Cheng JW
Ann Pharmacother; 2006 Oct; 40(10):1785-96. PubMed ID: 16985093
[TBL] [Abstract][Full Text] [Related]
19. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic, antiinflammatory drugs? Arguments against.
Weber AA; Hohlfeld T; Harder S
Thromb Haemost; 2006 Oct; 96(4):413-6. PubMed ID: 17003916
[TBL] [Abstract][Full Text] [Related]
20. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
Hermann M; Ruschitzka F
Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
